126 related articles for article (PubMed ID: 830420)
1. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.
Bertino JR; Sawicki WL; Lindquist CA; Gupta VS
Cancer Res; 1977 Jan; 37(1):327-8. PubMed ID: 830420
[TBL] [Abstract][Full Text] [Related]
2. [The mechanism of biochemical modulation in methotrexate/5-fluorouracil sequential chemotherapy].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Uchida J
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2591-4. PubMed ID: 7979418
[TBL] [Abstract][Full Text] [Related]
3. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
Heppner GH; Calabresi P
Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
[TBL] [Abstract][Full Text] [Related]
4. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
Sirotnak FM; Moccio DM; Dorick DM
Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?
Browman GP
Cancer Treat Rep; 1984 Mar; 68(3):465-9. PubMed ID: 6200218
[No Abstract] [Full Text] [Related]
6. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
7. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
8. Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.
Benz C; Tillis T; Tattelman E; Cadman E
Cancer Res; 1982 May; 42(5):2081-6. PubMed ID: 6175406
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
Iigo M; Kuretani K; Hoshi A
Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
11. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
Fernandes DJ; Moroson BA; Bertino JR
Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
[TBL] [Abstract][Full Text] [Related]
12. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
[TBL] [Abstract][Full Text] [Related]
13. [The significance of measuring inhibition of thymidylate synthase activity as a parameter for antitumor activity of 5-fluorouracil derivatives].
Takeda S; Uchida J; Yamada Y; Unemi N; Fujii S
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2125-30. PubMed ID: 3395138
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of methotrexate--with emphasis on use of high doses.
Bertino JR
Cancer Treat Rep; 1981; 65 Suppl 1():131-5. PubMed ID: 6976829
[TBL] [Abstract][Full Text] [Related]
15. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
Elliott WL; Howard CT; Dykes DJ; Leopold WR
Cancer Res; 1989 Oct; 49(20):5586-90. PubMed ID: 2477146
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
17. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
19. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
Bertino JR; Mini E; Fernandes DJ
Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
[TBL] [Abstract][Full Text] [Related]
20. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
[No Abstract] [Full Text] [Related]
[Next] [New Search]